Adrenal tumors can affect kidney function through several distinct pathways, and the impact is often more significant than many people realize. Some tumors damage the kidneys by flooding the body with hormones that raise blood pressure, alter electrolytes, or drive metabolic disease. Others grow large enough to physically invade kidney tissue. The type of tumor and the hormones it produces determine how much risk your kidneys face.
How Hormone-Producing Tumors Harm the Kidneys
Most adrenal tumors that affect kidney function do so indirectly, by overproducing hormones that create a hostile environment for delicate kidney tissue. The adrenal glands sit directly on top of each kidney and produce hormones that regulate blood pressure, stress responses, and electrolyte balance. When a tumor disrupts that production, the kidneys are among the first organs to feel the consequences.
Three types of hormone-secreting adrenal tumors pose the greatest risk to kidney health: those that overproduce aldosterone, those that release excess adrenaline-like hormones, and those that pump out too much cortisol. Each damages the kidneys through a different mechanism, but all share one common thread: uncontrolled high blood pressure that gradually wears down the kidney’s filtering units.
Aldosterone-Producing Tumors Carry the Highest Risk
Aldosterone is the hormone that tells your kidneys how much salt and water to retain. When an adrenal tumor overproduces it, a condition called primary aldosteronism, the kidneys hold onto too much sodium and lose too much potassium. Blood pressure climbs, and the excess aldosterone directly inflames and scars kidney tissue through several mechanisms: it triggers the buildup of fibrous tissue, generates damaging molecules called free radicals, and disrupts the lining of blood vessels inside the kidney.
The kidney damage from these tumors goes well beyond what you’d expect from high blood pressure alone. In a case-control study comparing patients with aldosterone-producing tumors to those with ordinary high blood pressure of the same severity, 18.4% of the tumor patients already had chronic kidney disease at the time of diagnosis, compared to just 2.1% of those with regular hypertension. That ninefold difference, after matching for age, sex, and blood pressure levels, points to aldosterone itself as a direct toxin to kidney tissue.
Chronic low potassium from these tumors also takes its own toll on the kidneys, a condition sometimes called hypokalemic nephropathy. When potassium stays too low for too long, the kidney’s ability to concentrate urine breaks down. People with this problem often notice they’re urinating frequently and feeling unusually thirsty, symptoms that can be mistaken for diabetes before the real cause is identified.
Adrenaline-Producing Tumors and Acute Kidney Injury
Pheochromocytomas are adrenal tumors that release surges of adrenaline and related hormones, causing episodes of severe high blood pressure, rapid heartbeat, sweating, and headaches. These blood pressure spikes can be extreme enough to qualify as hypertensive emergencies, and the kidneys are particularly vulnerable during these episodes.
A large propensity-matched analysis of hospitalized patients found that people with pheochromocytomas who experienced hypertensive emergencies had 54% higher odds of developing acute kidney injury compared to other patients with equally severe blood pressure crises. Their hospital stays averaged 7.5 days versus 6 days for matched controls. The repeated hammering of high-pressure blood through the kidney’s tiny filtering vessels can cause both sudden injury and, over time, lasting damage if the tumor goes undiagnosed.
Cortisol-Producing Tumors and Metabolic Kidney Damage
Adrenal tumors that overproduce cortisol cause Cushing’s syndrome, which damages kidneys through a more roundabout but no less serious route. Excess cortisol promotes insulin resistance, high blood sugar, abnormal cholesterol levels, and high blood pressure. Each of these metabolic problems independently harms the kidneys, and together they accelerate decline in kidney function.
The overlap between cortisol excess and kidney disease is striking. Cushing’s syndrome produces the same constellation of complications commonly seen in people with chronic kidney disease: cardiovascular damage, muscle wasting, bone loss, and immune dysfunction. Even subtle cortisol overproduction from small adrenal tumors, levels that might not cause obvious Cushing’s symptoms, has been linked to impaired blood sugar control and elevated blood pressure that can quietly erode kidney health over years.
Large Tumors Can Physically Invade the Kidney
While most adrenal tumors affect the kidneys through hormonal pathways, adrenal cancers (adrenocortical carcinomas) can grow large enough to directly invade surrounding organs. In the cancer staging system used by the National Cancer Institute, a tumor that invades the kidney, the renal vein, or the large vein draining into the heart is classified as stage T4, the most advanced local stage. This kind of direct invasion can obstruct blood flow to or from the kidney, compress kidney tissue, and severely impair function on the affected side.
Adrenocortical carcinomas are rare, affecting roughly one to two people per million each year. But because they often grow silently, they can reach considerable size before detection. A large tumor sitting on top of the kidney may compress the renal vein even without true invasion, reducing blood drainage and impairing the kidney’s ability to filter properly.
What Happens to Kidney Function After Tumor Removal
Here’s where the picture gets counterintuitive. You might expect kidney function to improve after removing an adrenal tumor, but for many patients, measured kidney function actually drops in the short term. A study tracking patients after surgery for aldosterone-producing tumors found that the average filtration rate fell from about 72 to 54 mL/min at one month after surgery, hitting its lowest point around three months. At one year, it recovered slightly to about 57.5 mL/min but remained significantly below the preoperative level.
About one-third of patients experienced a meaningful decline, and the proportion of patients meeting criteria for chronic kidney disease (filtration rate below 60) jumped from roughly 28% before surgery to more than half at one year after. One in three patients who had normal or mildly reduced kidney function before surgery progressed to a chronic kidney disease category within a year of tumor removal.
This doesn’t mean surgery made things worse in the way it might sound. What’s likely happening is that excess aldosterone had been artificially inflating the kidney’s filtration rate by forcing the kidneys to retain extra fluid and maintain high pressure within the filtering units. Once the hormone source is removed, the kidneys’ true baseline function is unmasked. Think of it like removing a turbocharger from an engine: the readings drop, but what you’re seeing is the real output, not a new problem. The underlying kidney damage was there all along, hidden by the very hormone causing it.
This unmasking effect is one reason early diagnosis matters so much. The longer an adrenal tumor pumps out excess hormones, the more irreversible scarring accumulates in the kidneys. Aldosterone receptor-blocking medications can help reverse some vascular and filtering-unit damage when used alongside other treatments, but fibrosis that has already set in is much harder to undo.
Signs That an Adrenal Tumor May Be Affecting Your Kidneys
The tricky part is that kidney damage from adrenal tumors rarely announces itself with obvious symptoms until it’s fairly advanced. The earliest clues are often indirect:
- Resistant high blood pressure that doesn’t respond well to standard medications, particularly in younger patients or those without typical risk factors
- Low potassium on blood tests, especially if it recurs without a clear dietary or medication cause
- Excessive urination and thirst, which can signal hypokalemic nephropathy from an aldosterone-producing tumor
- Protein in the urine, an early marker of kidney filtering damage that may show up on routine urinalysis
- Episodes of severe blood pressure spikes with sweating, headaches, or rapid heartbeat, which suggest a pheochromocytoma
If you’ve been diagnosed with an adrenal tumor, or if you have high blood pressure paired with unexplained potassium problems, kidney function testing with both filtration rate estimates and urine protein checks gives the most complete picture of whether kidney damage is developing.